LIPOSOMAL DOXORUBICIN: 19 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
19
Total FAERS Reports
1 (5.3%)
Deaths Reported
8
Hospitalizations
19
As Primary/Secondary Suspect
4
Life-Threatening
First Report: 20090214 · Latest Report: 20140401
What Are the Most Common LIPOSOMAL DOXORUBICIN Side Effects?
#1 Most Reported
Flushing
6 reports (31.6%)
#2 Most Reported
Infusion related reaction
5 reports (26.3%)
#3 Most Reported
Dyspnoea
5 reports (26.3%)
All LIPOSOMAL DOXORUBICIN Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Flushing | 6 | 31.6% | 0 | 2 |
| Dyspnoea | 5 | 26.3% | 0 | 1 |
| Infusion related reaction | 5 | 26.3% | 0 | 1 |
Who Reports LIPOSOMAL DOXORUBICIN Side Effects? Age & Gender Data
Average age: 58.3 years. Most reports from: US. View detailed demographics →
Is LIPOSOMAL DOXORUBICIN Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2009 | 1 | 0 | 1 |
| 2013 | 7 | 0 | 3 |
| 2014 | 7 | 0 | 3 |
What Is LIPOSOMAL DOXORUBICIN Used For?
| Indication | Reports |
|---|---|
| Neoplasm malignant | 6 |
Official FDA Label for LIPOSOMAL DOXORUBICIN
Official prescribing information from the FDA-approved drug label.